4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-23-008825
Chief Executive Officer acquired 168,512 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hively Brad Chief Executive Officer | 2023-03-17 | Grant or award | +168,512 | 724,182 | D | ||
| Derivatives | |||||||
| Hively Brad Chief Executive Officer | 2023-03-17 | Grant or award · Non-Qualified Stock Option (right to buy) | +421,280 | 421,280 | D | ||
Loading xslF345X04/wf-form4_167944585635107.xml…